Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).

被引：0
|
作者：
Sarkaria, Jann Nagina
Ballman, Karla V.
Kizilbash, Sani Haider
Sulman, Erik P.
Giannini, Caterina
Mashru, Sandeep H.
Piccioni, David Eric
Friday, Bret Edward Buckley
Dixon, Jesse G.
Kabat, Brian
Laack, Nadia N.
Hu, Leland
Kumthekar, Priya
Ellingson, Benjamin M.
Anderson, S. Keith
Galanis, Evanthia
机构：
[1] Mayo Clin, Rochester, MN USA
[2] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA
[3] Mayo Clin, Div Med Oncol, Rochester, MN USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] NW Kaiser Permanente, Portland, OR USA
[6] Univ Calif San Diego, Moores Canc Ctr, Ctr Personalized Canc Therapy, San Diego, CA USA
[7] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, San Diego, CA USA
[8] SMDC, Duluth, MN USA
[9] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[10] Mayo Clin, Phoenix, AZ USA
[11] Univ Chicago, Alliance Protocol Operat Off, Chicago, IL USA
[12] Univ Calif Los Angeles, Brain Res Inst, Dept Radiol, Radiol, Los Angeles, CA USA
[13] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2001
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Grossman, S. A.
    Ye, X.
    Chamberlain, M. C.
    Mikkelsen, T.
    Batchelor, T. T.
    Desideri, S.
    Piantadosi, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] PHASE III TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) TOGETHER WITH TEMOZOLOMIDE (TMZ) COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Farber, Ori
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2013, 15 : 76 - 77
  • [23] FINAL ANALYSIS OF ACT III: A PHASE II TRIAL OF PF-04948568 (CDX-110) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lai, Rose K.
    Recht, Lawrence D.
    Reardon, David A.
    Paleologos, Nina
    Groves, Morris
    Rosenfeld, Myrna R.
    Meech, Sandra
    Davis, Tom
    Pavlov, Dmitri
    Marshall, Margaret A.
    Sampson, John
    NEURO-ONCOLOGY, 2010, 12 : 76 - 77
  • [24] Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
    Gilbert, Mark R.
    Wang, Meihua
    Aldape, Kenneth D.
    Stupp, Roger
    Hegi, Monika E.
    Jaeckle, Kurt A.
    Armstrong, Terri S.
    Wefel, Jeffrey S.
    Won, Minhee
    Blumenthal, Deborah T.
    Mahajan, Anita
    Schultz, Christopher J.
    Erridge, Sara
    Baumert, Brigitta
    Hopkins, Kristen I.
    Tzuk-Shina, Tzahala
    Brown, Paul D.
    Chakravarti, Arnab
    Curran, Walter J., Jr.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4085 - +
  • [25] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [26] Hypofractionated accelerated radiotherapy (HART) with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM)
    Mallick, Supriya
    Haresh, K. P.
    Gupta, Subhash
    Sharma, Seema
    Laviraj, M. A.
    Upadhyay, Ashish Dutt
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
    Reddy, Krishna
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Stuhr, Kelly
    Kavanagh, Brian D.
    Chen, Changhu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : 655 - 660
  • [28] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [29] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [30] Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
    Brandes, Alba A.
    Tosoni, Alicia
    Franceschi, Enrico
    Sotti, Guido
    Frezza, Giampiero
    Amista, Pietro
    Morandi, Luca
    Spagnolli, Federica
    Ermani, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1275 - 1279
12345